The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells.
Open accessAbstract
We report evidence that FcR(CD16) on human NK cells are signal-transducing molecules that, upon ligand binding, induce transcription of genes encoding surface activation molecules [IL-2-R(CD25)] and cytokines (IFN-gamma and TNF) relevant to NK cell biology and functions. Homogeneous NK and T cell populations purified from short-term bulk cultures of PBMC with irradiated B lymphoblastoid cell lines were cultured in the presence of FcR ligands (particulate immune complexes or immobilized anti-CD16 antibodies) alone or with rIL-2. Upon 18 h of stimulation, NK cells express Tac, TfR, and 4F2 antigens and produce IFN-gamma and TNF; both effects are synergistically enhanced in the presence of rIL-2, which is itself ineffective. Treatment of NK cells with FcR(CD16) ligands induces accumulation of mRNA for IFN-gamma and TNF and, to a lesser extent, IL-2-R with fast kinetics also in the absence of de novo protein synthesis. rIL-2 and FcR(CD16) ligands synergize to induce mRNA accumulation. mRNA accumulation and transcription of TNF and IFN-gamma genes induced by FcR(CD16) ligands are greater than those induced by rIL-2, and the reverse is true for IL-2-R. The two stimuli do not synergize at the transcriptional level. These observations indicate that the mechanisms through which FcR(CD16) ligands and rIL-2 induce NK cell activation are, in part, distinct. Both operate at the transcriptional level, although other mechanisms are probably induced by the FcR ligand stimulus per se or in combination with other lymphokines and synergize at a post-transcriptional or translational level to enhance NK cell activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lanier, L. L., Le, A. M., Civin, C. I., Loken, M. R., & Phillips, J. H. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.12.4480 · Cited by 1,129
Transcriptional regulation of hemoglobin switching in chicken embryos.
Groudine, M., Peretz, M., & Weintraub, H. (1981) · Molecular and Cellular Biology · doi:10.1128/mcb.1.3.281 · Cited by 774
Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.
Krönke, M., Leonard, W. J., Depper, J. M., Arya, S. K., Wong-Staal, F., Gallo, R. C., Waldmann, T. A., & Greene, W. C. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.16.5214 · Cited by 605
Response of resting human peripheral blood natural killer cells to interleukin 2.
Trinchieri, G., Matsumoto-Kobayashi, M., Clark, S. C., Seehra, J., London, L., & Perussia, B. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.4.1147 · Cited by 604
Self-citationHuman neutrophil Fc gamma receptor distribution and structure.
Fleit, H. B., Wright, S. D., & Unkeless, J. C. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.10.3275 · Cited by 564
The Receptor with High Affinity for Immunoglobulin E
Metzger, H. (1986) · Annual Review of Immunology · doi:10.1146/annurev.immunol.4.1.419 · Cited by 543
Collart, M. A., Belin, D., Vassalli, J. D., de Kossodo, S., & Vassalli, P. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.6.2113 · Cited by 524
Meuer, S. C., Hussey, R. E., Cantrell, D. A., Hodgdon, J. C., Schlossman, S. F., Smith, K. A., & Reinherz, E. L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.5.1509 · Cited by 495
Scheurich, P., Thoma, B., Ucer, U., & Pfizenmaier, K. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.6.1786 · Cited by 492
Perussia, B., Starr, S., Abraham, S., Fanning, V, & Trinchieri, G. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.5.2133 · Cited by 409
Self-citation
Cited by
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Self-citationLanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M., & Trinchieri, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.3.1041 · Cited by 1,385
Self-citationIgG placental transfer in healthy and pathological pregnancies
Palmeira, P., Quinello, C., Silveira-Lessa, A. L., Zago, C. A., & Carneiro-Sampaio, M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/985646 · Cited by 1,037
Chan, S. H., Perussia, B., Gupta, J. W., Kobayashi, M., Pospísil, M., Young, H. A., Wolf, S. F., Young, D., Clark, S. C., & Trinchieri, G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.4.869 · Cited by 961
Self-citationBiology and clinical relevance of human natural killer cells
Robertson, M., & Ritz, J. (1990) · Blood · doi:10.1182/blood.v76.12.2421.2421 · Cited by 931
Regulation of human NK-cell cytokine and chemokine production by target cell recognition
Fauriat, C., Long, E. O., Ljunggren, H.-G., & Bryceson, Y. T. (2010) · Blood · doi:10.1182/blood-2009-08-238469 · Cited by 891
Wu, J., Edberg, J. C., Redecha, P. B., Bansal, V, Guyre, P. M., Coleman, K., Salmon, J. E., & Kimberly, R. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119616 · Cited by 711
Krapp, S., Mimura, Y., Jefferis, R., Huber, R., & Sondermann, P. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01250-0 · Cited by 674
The Dynamic Life of Natural Killer Cells
Yokoyama, W. M., Kim, S., & French, A. R. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104711 · Cited by 577
Ravetch, J. V., & Perussia, B. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.2.481 · Cited by 569
Self-citationRomee, R., Foley, B., Lenvik, T., Wang, Y., Zhang, B., Ankarlo, D., Luo, X., Cooley, S., Verneris, M., Walcheck, B., et al. (2013) · Blood · doi:10.1182/blood-2012-04-425397 · Cited by 552
Prospects for the use of NK cells in immunotherapy of human cancer
Ljunggren, H.-G., & Malmberg, K.-J. (2007) · Nature Reviews Immunology · doi:10.1038/nri2073 · Cited by 543
Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions
Tseng, C.-T. K., & Klimpel, G. R. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011145 · Cited by 447
Hidalgo, L. G., Sis, B., Sellares, J., Campbell, P. M., Mengel, M., Einecke, G., Chang, J., & Halloran, P. F. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03201.x · Cited by 428
Biology of Human Immunoglobulin G Fc Receptors
van de Winkel, J. G. J., & Anderson, C. L. (1991) · Journal of Leukocyte Biology · doi:10.1002/jlb.49.5.511 · Cited by 392
Moretta, A., Bottino, C., Pende, D., Tripodi, G., Tambussi, G., Viale, O., Orengo, A., Barbaresi, M., Merli, A., & Ciccone, E. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1589 · Cited by 385
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Peng, L., Sferruzza, G., Yang, L., Zhou, L., & Chen, S. (2024) · Cellular & Molecular Immunology · doi:10.1038/s41423-024-01207-0 · Cited by 373
On guard—activating NK cell receptors
Lanier, L. L. (2001) · Nature Immunology · doi:10.1038/83130 · Cited by 346
Interferon-Induced Antiviral Actions and Their Regulation
Sen, G. C., & Ransohoff, R. M. (1993) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60083-4 · Cited by 334
Oliva, A., Kinter, A. L., Vaccarezza, M., Rubbert, A., Catanzaro, A., Moir, S., Monaco, J., Ehler, L., Mizell, S., Jackson, R., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2323 · Cited by 291
Mond, J. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80109-x · Cited by 288
Transcriptional Control of the TNF Gene
Falvo, J. V., Tsytsykova, A. V., & Goldfeld, A. E. (2010) · Current Directions in Autoimmunity · doi:10.1159/000289196 · Cited by 281
A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival
Teitelbaum, R., Glatman-Freedman, A., Chen, B., Robbins, J. B., Unanue, E., Casadevall, A., & Bloom, B. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15688 · Cited by 275
Dynamics of immunoglobulins at the feto-maternal interface
Saji, F. (1999) · Reviews of Reproduction · doi:10.1530/revreprod/4.2.81 · Cited by 265
Wing, M. G., Moreau, T., Greenwood, J., Smith, R. M., Hale, G., Isaacs, J., Waldmann, H., Lachmann, P. J., & Compston, A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119110 · Cited by 257
Role of Oligosaccharide Residues of IgG1-Fc in FcγRIIb Binding
Mimura, Y., Sondermann, P., Ghirlando, R., Lund, J., Young, S. P., Goodall, M., & Jefferis, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107478200 · Cited by 236
Effector Mechanisms of Rejection
Moreau, A., Varey, E., Anegon, I., & Cuturi, M.-C. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015461 · Cited by 189
Self-citationDevelopments and Challenges for mAb-Based Therapeutics
Goswami, S., Wang, W., Arakawa, T., & Ohtake, S. (2013) · Antibodies · doi:10.3390/antib2030452 · Cited by 144
Azzoni, L., Kamoun, M., Salcedo, T. W., Kanakaraj, P., & Perussia, B. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1745 · Cited by 106
Self-citationAzzoni, L., Zatsepina, O., Abebe, B., Bennett, I. M., Kanakaraj, P., & Perussia, B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3493 · Cited by 105
Self-citationGenome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
Shankar, K., Capitini, C. M., & Saha, K. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01741-4 · Cited by 85
Metadata
- Authors
- Anegón, I., Cuturi, M. C., Trinchieri, G., & Perussia, B.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1988-02-01
- Volume
- 167
- Issue
- 2
- Pages
- 452-472
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2127022844
- Cited by
- 368
- References
- 38
- FWCI
- 12.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.